+32 (0)476 83 07 50
Founded in April 2014 in Grenoble (France) as a spin-off of the French Blood Bank (Etablissement Français du Sang, EFS), PDC*line Pharma is a Belgian-French biotech company that is developing a novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) pre-loaded with peptides that are derived from target tumor antigens.
After a first-in-human feasibility clinical study in melanoma, PDC*line Pharma is focusing on lung cancer with a new candidate in phase 1b/2 clinical trial (PDC*lung) and neoantigens (PDC*Neo). The company currently comprises for 25 people and has an experienced management team. In March 2019, PDC*line signed a licensing deal with a leading Korean pharmaceutical companyfor the development and commercialization of PDC*lung cancer vaccine for lung cancer in Asia. The total deal value is 108M€ (123M$) plus tiered royalties on sales. The company then closed in December of a 20M€ B Round of financing led by the multi billion Asian VC KIP (Korea Investment Partners).
In order to support the rapid development and strengthen our financial & administrative organization, we are actively looking for a (m/f): Risk & Compliance Manager.
As a Risk & Compliance Manager, you ensure that the company is compliant with appropriate regulatory and administrative requirements for public companies. Working closely with the CFO/COO, you participate to the development of the company according to the different (financial and non-financial) standards.
Your application and related information will remain strictly confidential.